Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 22, Number 10—October 2016
CME ACTIVITY - Research

Ebola Virus Disease in Children, Sierra Leone, 2014–2015

Felicity FitzgeraldComments to Author , Asad Naveed, Kevin Wing, Musa Gbessay, J.C.G. Ross, Francesco Checchi, Daniel Youkee, Mohammed Boie Jalloh, David E. Baion, Ayeshatu Mustapha, Hawanatu Jah, Sandra Lako, Shefali Oza, Sabah Boufkhed, Reynold Feury, Julia Bielicki, Diana M. Gibb, Nigel Klein, Foday Sahr, and Shunmay Yeung
Author affiliations: Save the Children, London, UK (F. Fitzgerald, J.C.G. Ross, F. Checchi); University College of London Great Ormond Street Institute of Child Health, London (F. Fitzgerald, N. Klein); Save the Children, Freetown, Sierra Leone (A. Naveed, M. Gbessay); London School of Hygiene & Tropical Medicine, London (K. Wing, F. Checchi, S. Oza, S. Boufkhed, S. Yeung); Kings Sierra Leone Partnership—Connaught Hospital, Freetown (D. Youkee); Republic of Sierra Leone Armed Forces, Freetown (M.B. Jalloh, F. Sahr); Ola During Children’s Hospital—Sierra Leone Ministry of Health, Freetown (D. Baion, A. Mustapha); Cap Anamur (German Emergency Doctors)—Ola During Children’s Hospital, Freetown (H. Jah); Welbodi Partnership—Ola During Children’s Hospital, Freetown (S. Lako); Western Area Emergency Response Centre, Freetown (R. Feury); St. George’s University of London, London, UK (J.A. Bielicki); MRC Clinical Trials Unit at University College of London, London (J.A. Bielicki, D.M. Gibb)

Main Article

Figure 1

Patient care pathway of EHUs, Western Area (including Freetown), Sierra Leone, August 2014–March 2015. The OICC was set up to care for children with substantial Ebola virus exposure (usually a first-degree relative with confirmed EVD) and without relatives to care for them during the 21-day incubation period. Figure reproduced from (8) (Creative Commons License). EHU, Ebola holding unit; EVD, Ebola virus disease; OICC, observational interim care center.

Figure 1. Patient care pathway of EHUs, Western Area (including Freetown), Sierra Leone, August 2014–March 2015. The OICC was set up to care for children with substantial Ebola virus exposure (usually a first-degree relative with confirmed EVD) and without relatives to care for them during the 21-day incubation period. Figure reproduced from (8) (Creative Commons License). EHU, Ebola holding unit; EVD, Ebola virus disease; OICC, observational interim care center.

Main Article

References
  1. World Health Organization. Ebola data and statistics [cited 2015 Sep 18]. http://apps.who.int/gho/data/node.ebola-sitrep.quick-downloads?lang=en
  2. Chertow  DS, Kleine  C, Edwards  JK, Scaini  R, Giuliani  R, Sprecher  A. Ebola virus disease in West Africa—clinical manifestations and management. N Engl J Med. 2014;371:2054–7.DOIPubMedGoogle Scholar
  3. Agua-Agum  J, Ariyarajah  A, Blake  IM, Cori  A, Donnelly  CA, Dorigatti  I, ; WHO Ebola Response Team. Ebola virus disease among children in West Africa. N Engl J Med. 2015;372:1274–7.DOIPubMedGoogle Scholar
  4. Mupere  E, Kaducu  OF, Yoti  Z. Ebola haemorrhagic fever among hospitalised children and adolescents in northern Uganda: epidemiologic and clinical observations. Afr Health Sci. 2001;1:60–5.PubMedGoogle Scholar
  5. WHO Ebola Response Team. Ebola virus disease in West Africa—the first 9 months of the epidemic and forward projections. N Engl J Med. 2014;371:1481–95.DOIPubMedGoogle Scholar
  6. Johnson  O, Brown  CS, Lado  M, Wurie  A, Bash-Taqi  D, Hall  A, Ebola holding units at government hospitals in Sierra Leone: evidence for a flexible and effective model for safe isolation, early treatment initiation, hospital safety, and health system functioning. BMJ Global Health. 2016;1:e000030 .DOIGoogle Scholar
  7. Brown  C, Kessete  Q, Baker  P, Youkee  D, Walker  N, Kamara  TB, Bottlenecks in health systems functioning for control of Ebola virus disease in Connaught Hospital, Freetown, Sierra Leone. Poster P0092. Presented at: 26th European Congress of Clinical Microbiology and Infectious Diseases; 2016 Apr 9–12; Amsterdam, the Netherlands.
  8. Fitzgerald  F, Awonuga  W, Shah  T, Youkee  D. Ebola response in Sierra Leone: The impact on children. J Infect. 2016;72(Suppl):S6–12.DOIPubMedGoogle Scholar
  9. Agua-Agum  J, Ariyarajah  A, Aylward  B, Blake  IM, Brennan  R, Cori  A, ; WHO Ebola Response Team. West African Ebola epidemic after one year—slowing but not yet under control. N Engl J Med. 2015;372:584–7.DOIPubMedGoogle Scholar
  10. Dietz  PM, Jambai  A, Paweska  JT, Yoti  Z, Ksiazek  TG. Epidemiology and risk factors for Ebola virus disease in Sierra Leone-23 May 2014 to 31 January 2015. Clin Infect Dis. 2015;61:1648–54.PubMedGoogle Scholar
  11. Ansumana  R, Jacobsen  KH, Sahr  F, Idris  M, Bangura  H, Boie-Jalloh  M, Ebola in Freetown area, Sierra Leone—a case study of 581 patients. N Engl J Med. 2015;372:587–8.DOIPubMedGoogle Scholar
  12. Hunt  L, Gupta-Wright  A, Simms  V, Tamba  F, Knott  V, Tamba  K, Clinical presentation, biochemical, and haematological parameters and their association with outcome in patients with Ebola virus disease: an observational cohort study. Lancet Infect Dis. 2015;15:1292–9.DOIPubMedGoogle Scholar
  13. Lado  M, Walker  NF, Baker  P, Haroon  S, Brown  CS, Youkee  D, Clinical features of patients isolated for suspected Ebola virus disease at Connaught Hospital, Freetown, Sierra Leone: a retrospective cohort study. Lancet Infect Dis. 2015;15:1024–33.DOIPubMedGoogle Scholar
  14. MacDermott  NE, De  S, Herberg  JA. Viral haemorrhagic fever in children. Arch Dis Child. 2016;101:461–8.DOIPubMedGoogle Scholar
  15. World Health Organization. Clinical management of patients in the Ebola treatment centres and other care centres in Sierra Leone: a pocket guide. Interim emergency guidelines. Sierra Leone adaptation. Geneva: The Organization; 2014
  16. Kreuels  B, Wichmann  D, Emmerich  P, Schmidt-Chanasit  J, de Heer  G, Kluge  S, A case of severe Ebola virus infection complicated by gram-negative septicemia. N Engl J Med. 2014;371:2394–401.DOIPubMedGoogle Scholar
  17. White  IR, Royston  P, Wood  AM. Multiple imputation using chained equations: Issues and guidance for practice. Stat Med. 2011;30:377–99.DOIPubMedGoogle Scholar
  18. Qin  E, Bi  J, Zhao  M, Wang  Y, Guo  T, Yan  T, Clinical features of patients with Ebola virus disease in Sierra Leone. Clin Infect Dis. 2015;61:491–5.DOIPubMedGoogle Scholar
  19. McElroy  AK, Erickson  BR, Flietstra  TD, Rollin  PE, Nichol  ST, Towner  JS, Biomarker correlates of survival in pediatric patients with Ebola virus disease. Emerg Infect Dis. 2014;20:1683–90.DOIPubMedGoogle Scholar
  20. Olupot-Olupot  P. Ebola in children: epidemiology, clinical features, diagnosis and outcomes. Pediatr Infect Dis J. 2015;34:314–6.DOIPubMedGoogle Scholar
  21. Sadek  RF, Khan  AS, Stevens  G, Peters  CJ, Ksiazek  TG. Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995: determinants of survival. J Infect Dis. 1999;179(Suppl 1):S24–7.DOIPubMedGoogle Scholar
  22. Jamieson  DJ, Uyeki  TM, Callaghan  WM, Meaney-Delman  D, Rasmussen  SA. What obstetrician-gynecologists should know about Ebola: a perspective from the Centers for Disease Control and Prevention. Obstet Gynecol. 2014;124:1005–10.DOIPubMedGoogle Scholar
  23. Ebola haemorrhagic fever in Zaire, 1976. Bull World Health Organ. 1978;56:271–93.PubMedGoogle Scholar
  24. Bah  EI, Lamah  MC, Fletcher  T, Jacob  ST, Brett-Major  DM, Sall  AA, Clinical presentation of patients with Ebola virus disease in Conakry, Guinea. N Engl J Med. 2015;372:40–7.DOIPubMedGoogle Scholar
  25. Sissoko  D, Laouenan  C, Folkesson  E, M’Lebing  AB, Beavogui  AH, Baize  S, ; JIKI Study Group. Experimental treatment with favipiravir for Ebola virus disease (the JIKI Trial): a historically controlled, single-arm proof-of-concept trial in Guinea. PLoS Med. 2016;13:e1001967.DOIPubMedGoogle Scholar
  26. de La Vega  MA, Caleo  G, Audet  J, Qiu  X, Kozak  RA, Brooks  JI, Ebola viral load at diagnosis associates with patient outcome and outbreak evolution. J Clin Invest. 2015;125:4421–8.DOIPubMedGoogle Scholar
  27. Broadhurst  MJ, Kelly  JD, Miller  A, Semper  A, Bailey  D, Groppelli  E, ReEBOV Antigen Rapid Test kit for point-of-care and laboratory-based testing for Ebola virus disease: a field validation study. Lancet. 2015;386:867–74.DOIPubMedGoogle Scholar
  28. Li  J, Duan  HJ, Chen  HY, Ji  YJ, Zhang  X, Rong  YH, Age and Ebola viral load correlate with mortality and survival time in 288 Ebola virus disease patients. Int J Infect Dis. 2016;42:34–9.DOIPubMedGoogle Scholar
  29. Gignoux  E, Azman  AS, de Smet  M, Azuma  P, Massaquoi  M, Job  D, Effect of artesunate-amodiaquine on mortality related to Ebola virus disease. N Engl J Med. 2016;374:23–32.DOIPubMedGoogle Scholar
  30. Owens  S, Leyland  T. Fighting Ebola in Sierra Leone: a view from the frontline. Arch Dis Child. 2016;101:284–6.DOIPubMedGoogle Scholar
  31. Aswani  V. Being a pediatrician in an Ebola epidemic. [Epub 2015 Dec 1]. Pediatrics. 2016;137:e20152950.DOIPubMedGoogle Scholar
  32. Francia  M. Surviving together, in Ebola-hit Sierra Leone [cited 2015 Nov 13]. http://www.unicef.org/infobycountry/sierraleone_80800.html
  33. Epstein  JM, Sauer  LM, Chelen  J, Hatna  E, Parker  J, Rothman  RE, Infectious disease: Mobilizing Ebola survivors to curb the epidemic. Nature. 2014;516:323–5.DOIPubMedGoogle Scholar
  34. Dowell  SF. Ebola hemorrhagic fever: why were children spared? Pediatr Infect Dis J. 1996;15:189–91.DOIPubMedGoogle Scholar
  35. Peacock  G, Uyeki  TM, Rasmussen  SA. Ebola virus disease and children: what pediatric health care professionals need to know. JAMA Pediatr. 2014;168:1087–8.DOIPubMedGoogle Scholar
  36. Glynn  JR. Age-specific incidence of Ebola virus disease. Lancet. 2015;386:432.DOIPubMedGoogle Scholar
  37. Barry  M, Traoré  FA, Sako  FB, Kpamy  DO, Bah  EI, Poncin  M, Ebola outbreak in Conakry, Guinea: epidemiological, clinical, and outcome features. Med Mal Infect. 2014;44:491–4.DOIPubMedGoogle Scholar
  38. Helleringer  S, Noymer  A, Clark  SJ, McCormick  T. Did Ebola relatively spare children? Lancet. 2015;386:1442–3.DOIPubMedGoogle Scholar
  39. Fitzgerald  F, Yeung  S, Gibb  DM, Baion  DE, Pollard  A. Ebola vaccination. Lancet. 2015;386:2478.DOIPubMedGoogle Scholar
  40. Longini  IM, Egger  M, Dean  NE, Edmunds  WJ, Henao-Restrepo  AM; study steering group. Ebola vaccination - Authors’ reply. Lancet. 2015;386:2480.DOIPubMedGoogle Scholar

Main Article

Page created: September 15, 2016
Page updated: September 15, 2016
Page reviewed: September 15, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external